Outpatient dermatology consultations for oncology patients with acute dermatologic adverse events impact anticancer therapy interruption: a retrospective study.
D M BarriosG S PhillipsA Freites-MartinezM HsuK CiccoliniA Skripnik LucasM A MarchettiA M RossiE H LeeL DengA MarkovaP L MyskowskiMario E LacouturePublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2020)
A high frequency of positive outcomes in the management of targeted therapy-induced dAEs by outpatient consulting dermatologists and low recurrence of skin toxicity suggests impactful reductions in interruption of anticancer therapy.